Aclaris Therapeutics, Inc.

DEUTSCHE BANK AG\ ACRS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

987,351

Value ($000)

2,972

Weight

0.0%

2018 Q2 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	2,972	0.0%	987,351	12/31/2025
2025 Q3	11/13/2025	1,754	0.0%	923,313	9/30/2025
2025 Q2	8/12/2025	1,429	0.0%	1,006,549	6/30/2025
2025 Q1	5/9/2025	1,413	0.0%	923,313	3/31/2025
2024 Q4	6/30/2025	2,290	0.0%	923,313	12/31/2024
2024 Q3	6/26/2025	1,062	0.0%	923,313	9/30/2024
2024 Q2	6/12/2025	1,016	0.0%	923,313	6/30/2024
2024 Q1	6/2/2025	1,187	0.0%	957,021	3/31/2024
2023 Q4	2/14/2024	981	0.0%	934,046	12/31/2023
2023 Q3	11/24/2023	1,057	0.0%	154,309	9/30/2023
2023 Q2	8/14/2023	11,268	0.0%	1,086,620	6/30/2023
2023 Q1	5/15/2023	8,917	0.0%	1,102,197	3/31/2023
2022 Q4	2/13/2023	18,547	0.0%	1,177,593	12/31/2022
2022 Q3	11/14/2022	18,399	0.0%	1,168,897	9/30/2022
2022 Q2	8/11/2022	16,399	0.0%	1,174,701	6/30/2022
2022 Q1	5/13/2022	25,293	0.0%	1,467,103	3/31/2022
2021 Q4	2/16/2022	3,694	0.0%	254,071	12/31/2021
2021 Q3	11/4/2021	5,804	0.0%	322,439	9/30/2021
2021 Q2	8/11/2021	5,868	0.0%	334,234	6/30/2021
2021 Q1	5/13/2021	6,520	0.0%	258,711	3/31/2021
2020 Q4	2/16/2021	425	0.0%	65,628	12/31/2020
2020 Q3	11/12/2020	169	0.0%	65,628	9/30/2020
2020 Q2	8/13/2020	106	0.0%	65,628	6/30/2020
2020 Q1	5/14/2020	41	0.0%	39,023	3/31/2020
2019 Q4	2/14/2020	73	0.0%	39,651	12/31/2019
2018 Q3	12/21/2021	4,698	—	323,581	9/30/2018
2018 Q2	4/21/2020	4,579	—	229,275	6/30/2018